000			01573 a2200433 4500
005			20250512003909.0
264		0	_c19891219
008			198912s 0 0 eng d
022			_a0049-3848
024	7		_a10.1016/0049-3848(89)90395-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aPiszkiewicz, D
245	0	0	_aInactivation and removal of human immunodeficiency virus in monoclonal purified antihemophilic factor (human) (Hemofil M). _h[electronic resource]
260			_bThrombosis research _cSep 1989
300			_a627-34 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAcquired Immunodeficiency Syndrome _xprevention & control
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aCells, Cultured
650	0	4	_aChromatography, Affinity
650	0	4	_aEthylene Glycol
650	0	4	_aEthylene Glycols _xpharmacology
650	0	4	_aFactor VIII _xisolation & purification
650	0	4	_aHIV _xdrug effects
650	0	4	_aHIV Antibodies _ximmunology
650	0	4	_aHIV Antigens _xanalysis
650	0	4	_aHemophilia A _xtherapy
650	0	4	_aHumans
650	0	4	_aOctoxynol
650	0	4	_aOrganophosphates _xpharmacology
650	0	4	_aOrganophosphorus Compounds _xpharmacology
650	0	4	_aPolyethylene Glycols _xpharmacology
650	0	4	_aVirulence _xdrug effects
650	0	4	_aVirus Replication
700	1		_aSun, C S
700	1		_aTondreau, S C
773	0		_tThrombosis research _gvol. 55 _gno. 5 _gp. 627-34
856	4	0	_uhttps://doi.org/10.1016/0049-3848(89)90395-2 _zAvailable from publisher's website
999			_c2516356 _d2516356